The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients
- PMID: 23884506
The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients
Abstract
Atopic dermatitis (AD) may be considered the "poster disease" for exemplifying the significance of abnormalities of the epidermal barrier that occur predominantly within the stratum corneum (SC) and upper epidermis. Specifically, impairments of the SC permeability barrier, antimicrobial barrier, and immunologic barrier contribute markedly to the fundamental pathophysiology of AD. The multiple clinical sequelae associated with epidermal barrier impairments inherent to AD include dry skin, pruritus, increased skin sensitivity to irritants and allergens, eczematous skin changes, staphylococcal skin and anterior nares colonization, and increase in some cutaneous infections (ie, molluscum contagiosum). This article addresses the pathophysiology of AD with clinically relevant correlations, and discusses the scientific basis of a specially designed cleanser and moisturizer system that incorporates ceramide technology and filaggrin degradation products along with other "barrier-friendly" excipients.
Similar articles
-
Use of ceramides and related products for childhood-onset eczema.Recent Pat Inflamm Allergy Drug Discov. 2013 Jan 1;7(1):12-9. Recent Pat Inflamm Allergy Drug Discov. 2013. PMID: 23083072 Review.
-
Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products.J Cosmet Dermatol. 2006 Jun;5(2):140-9. doi: 10.1111/j.1473-2165.2006.00241.x. J Cosmet Dermatol. 2006. PMID: 17173589 Review.
-
A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides.Skin Therapy Lett. 2012 Jul;17(7):6-9. Skin Therapy Lett. 2012. PMID: 22825649 Review.
-
Barrier repair therapy in atopic dermatitis: an overview.Am J Clin Dermatol. 2013 Oct;14(5):389-99. doi: 10.1007/s40257-013-0033-9. Am J Clin Dermatol. 2013. PMID: 23757122 Review.
-
Atopic dermatitis, and the role for a ceramide-dominant, physiologic lipid-based barrier repair emulsion.J Drugs Dermatol. 2013 Sep;12(9):1024-7. J Drugs Dermatol. 2013. PMID: 24002150 Review.
Cited by
-
Excessive cleansing: an underestimating risk factor of rosacea in Chinese population.Arch Dermatol Res. 2021 May;313(4):225-234. doi: 10.1007/s00403-020-02095-w. Epub 2020 Jun 27. Arch Dermatol Res. 2021. PMID: 32594335
-
Proderm technology: a water- based lipid delivery system for dermatitis that penetrates viable epidermis and has antibacterial effects.BMC Dermatol. 2019 Jan 22;19(1):2. doi: 10.1186/s12895-019-0082-8. BMC Dermatol. 2019. PMID: 30670022 Free PMC article. Clinical Trial.
-
Performance and Tolerability of the Moisturizers Cetaphil® and Excipial® in Atopic Dermatitis: What is the Evidence Based on Randomized Trials?Dermatol Ther (Heidelb). 2017 Sep;7(3):331-347. doi: 10.1007/s13555-017-0184-3. Epub 2017 Jun 9. Dermatol Ther (Heidelb). 2017. PMID: 28600606 Free PMC article. Review.
-
Efficacy and Tolerability of Steroid-Free, Over-the-Counter Treatment Formulations in Infants and Children With Atopic Dermatitis.J Dermatol Nurses Assoc. 2015 Jan;7(1):17-24. doi: 10.1097/JDN.0000000000000101. J Dermatol Nurses Assoc. 2015. PMID: 25699134 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
